Myocardial viability assessment in 18FDG PET/CT study (18FDG PET myocardial viability assessment)
Nuclear Medicine Review · 2012
DOI: 10.5603/nmr-18731 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nuclear Medicine Review, 2012. Verfasst von Małgorzata Kobylecka und 5 weiteren Autor:innen. Beteiligte Einrichtung: Nuclear Medicine Department Warsaw Medical University, Warsaw, Poland. makob@amwaw.edu.pl. Hauptthemen laut MEDLINE: Fluorodeoxyglucose F18, Positron-Emission Tomography, Tissue Survival, Tomography, X-Ray Computed.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Nuclear Medicine Department Warsaw Medical University, Warsaw, Poland. makob@amwaw.edu.pl
Zitieren
APA
Kobylecka, M., Mączewska, J., Fronczewska-Wieniawska, K., Mazurek, T., Płazińska, M. T., & Królicki, L. (2012). Myocardial viability assessment in 18FDG PET/CT study (18FDG PET myocardial viability assessment). Nuclear Medicine Review. https://doi.org/10.5603/nmr-18731
Vancouver
Kobylecka M, Mączewska J, Fronczewska-Wieniawska K, Mazurek T, Płazińska MT, Królicki L. Myocardial viability assessment in 18FDG PET/CT study (18FDG PET myocardial viability assessment). Nuclear Medicine Review. 2012. doi:10.5603/nmr-18731
BibTeX
@article{Kobylecka2012,
author = {Kobylecka, Małgorzata and Mączewska, Joanna and Fronczewska-Wieniawska, Katarzyna and Mazurek, Tomasz and Płazińska, Maria Teresa and Królicki, Leszek},
title = {Myocardial viability assessment in 18FDG PET/CT study (18FDG PET myocardial viability assessment)},
journal = {Nuclear Medicine Review},
year = {2012},
doi = {10.5603/nmr-18731}
}
EUVIMED